|
BAG5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.321420E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.697990E-01 |
| Normal-vs-Stage2 |
4.987000E-01 |
| Normal-vs-Stage3 |
1.276030E-01 |
| Normal-vs-Stage4 |
3.973900E-02 |
| Stage1-vs-Stage2 |
6.084600E-01 |
| Stage1-vs-Stage3 |
8.000200E-01 |
| Stage1-vs-Stage4 |
3.123800E-01 |
| Stage2-vs-Stage3 |
5.063800E-01 |
| Stage2-vs-Stage4 |
2.404600E-01 |
| Stage3-vs-Stage4 |
5.062800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.396840E-01 |
| Normal-vs-AfricanAmerican |
9.911600E-01 |
| Normal-vs-Asian |
1.388220E-01 |
| Caucasian-vs-AfricanAmerican |
3.084800E-01 |
| Caucasian-vs-Asian |
7.027200E-01 |
| AfricanAmerican-vs-Asian |
2.718600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.262100E-02 |
| Normal-vs-Female |
2.079200E-01 |
| Male-vs-Female |
2.769600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.575800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.637420E-01 |
| Normal-vs-Age(61-80Yrs) |
2.942200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.587600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.227200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.923590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.118000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.629800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.529200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.718000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.106400E-01 |
| Classical-VS-Follicular |
6.441100E-04 |
| Classical-VS-Other |
2.178000E-02 |
| Classical-VS-Normal |
6.066800E-01 |
| Tall-VS-Follicular |
1.660760E-01 |
| Tall-VS-Other |
4.718200E-02 |
| Tall-VS-Normal |
3.316000E-01 |
| Follicular-VS-Other |
3.052800E-01 |
| Follicular-VS-Normal |
6.264100E-03 |
| Other-VS-Normal |
1.117990E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.192300E-02 |
| Normal-vs-N1 |
1.449520E-02 |
| N0-vs-N1 |
4.060600E-01 |
|
|
